Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Myovant Sciences GmbH

Home Clinical Trial Sponsors and OrganizationsMyovant Sciences GmbH

Myovant Sciences GmbH

ACTIVE

Switzerlandwww.myovant.comSubsidiary

Part of Myovant Sciences Ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

68

55 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

57

83.8%

Phase 3

8

11.8%

Phase 2

1

1.5%

Trial Status Distribution

Active, not recruiting

55

80.9%

Completed

13

19.1%

Clinical Trials

Trials sponsored by this organization (68)

Extension study to evaluate the efficacy and safety of Relugolix in Women with Endometriosis-Associated Pai

Active, not recruiting

May 2022800 participants

A study to evaluate the long term Efficacy and Safety of Relugolix in Women With Heavy Menstrual Bleeding Associated with Uterine Fibroids

Active, not recruiting

May 2021600 participants

A study to evaluate the long term Effect and Safety of Relugolix in Women With Heavy Menstrual Bleeding Associated with Uterine Fibroids

Active, not recruiting

Jan 2021250 participants

A research study planned as open-label in order to determine whether Relugolix has any serious side effects and to determine its medical benefits and investigate how it works in men with very serious prostate cancer.

Active, not recruiting

Jan 20211,100 participants

Extension study to evaluate the efficacy and safety of relugolix in women with endometriosis-associated pai

Active, not recruiting

Jan 2021800 participants

A Study of the Effects of Erythromycin on the Pharmacokinetics of Relugolix, Estradiol, and Norethindrone in Healthy Postmenopausal Women and on the Pharmacokinetics of Relugolix in Healthy Adult Men

Jan 202143 participants

A study to evaluate the efficacy and safety of relugolix in women with endometriosis-associated pai

Active, not recruiting

Nov 2020600 participants

A study to evaluate the long term Effect and Safety of Relugolix in Women With Heavy Menstrual Bleeding Associated with Uterine Fibroids

Active, not recruiting

Dec 2018360 participants

Page 1 of 9

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials68
Approvals
News

Back to Organizations